domestic approval
Scope
Date
~
-
Bio & Pharma
GC Biopharma gets WHO pre-qualification approval for chickenpox vaccine
South Korea's GC Biopharma Corp. is set to regain the No. 1 spot in global production of chickenpox vaccines after earning qualification to enter th...
Feb 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea United Pharm signs contract to supply medicines to Saudi Arabia
Korea United Pharm. Inc. announced on Monday that it signed a contract to supply nine types of medicines, including 11 anticancer drugs, to Saudi ph...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Brazil approves Celltrion Pharm’s syringe facility
Celltrion Pharm Inc., a South Korean biopharmaceutical company, said on Monday it received certification from Brazil’s health regulator for it...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Hwajin Medical gets FDA sales approval for syringes
HLB Therapeutics Co. announced Thursday that Sofjec, a syringe produced by its subsidiary Hwajin Medical, has been approved for sale by the US Food ...
Feb 17, 2023 (Gmt+09:00)
-
Bio & Pharma
EOFlow's insulin injection pump starts to be sold in UAE
South Korea's medical device maker EOFlow Co. started selling the wearable insulin pump EOPatch in the United Arab Emirates.The company said on Tues...
Feb 15, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N's GERD drug K-CAB gets approval in Mexico
South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Plasma, Janssen Korea sign sales, distribution agreement
SK Plasma Co. Ltd., a South Korean company specializing in the production of plasma derivatives from human plasma, is expanding its product portfoli...
Feb 14, 2023 (Gmt+09:00)
-
Construction
Korean builders to ramp up overseas business in 2023
Major South Korean construction firms are set to expand their overseas business while reducing domestic projects this year to boost profitability. T...
Feb 13, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB’s Rivoceranib, Hengrui's Camrelizumab approved as combination therapy in China
South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...
Feb 09, 2023 (Gmt+09:00)
-
Energy
Doosan Enerbility, Siemens Gamesa join forces for offshore wind power
Major South Korean power plant builder, Doosan Enerbility Co., has entered into a strategic partnership with the world's No. 1 offshore wind power c...
Feb 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong receives approval for its GERD drug Fexuclue in Ecuador
Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...
Feb 06, 2023 (Gmt+09:00)
-
Airlines
KAL introduces self-service bag drop for domestic flights
South Korea's flagship carrier Korean Air Lines Co. is the first airline in the country to adopt self-service bag drop on domestic flights.The compa...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience's SKYCellflu approved by Chilean health authority
SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, announced on Thursday that its world-first cell culture-based quadr...
Feb 02, 2023 (Gmt+09:00)
-
Banking & Finance
Korea's credit card approval volume hit all-time high last year
The annual card approval amount in South Korea exceeded 1,000 trillion won ($811.4 billion) for the first time ever. This is largely because of "ret...
Feb 01, 2023 (Gmt+09:00)
-
Carbon neutrality
Doosan advances domestic development of green hydrogen turbine
South Korea's Doosan Enerbility Co. on Sunday said it signed a memorandum of understanding on Friday with 10 domestic companies and universities at ...
Jan 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Nibec gets approval for its bone graft biomaterials in Colombia, Mexico
South Korea's bioactive peptide technology company Nibec Co. said on Friday that it has obtained product approval for the sale of two types of denta...
Jan 27, 2023 (Gmt+09:00)
-
Batteries
POSCO gets nod for battery technology transfer to overseas plants
POSCO Chemical Co., a unit of South Korean steelmaker POSCO Holdings Co., on Thursday won government approval to transfer technology to its overseas...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's botulinum toxin Nabota wins approval from Australia
Daewoong Pharmaceutical said on Wednesday that its botulinum toxin formulation Nabota (overseas brand name: Nuceiva) won approval in Australia on Ja...
Jan 26, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
Kolmar Korea to establish new cosmetics production base in Sejong City
South Korea's cosmetic original design manufacturer Kolmar Korea said Wednesday that it would establish a cosmetics production base equipped with ar...
Jan 25, 2023 (Gmt+09:00)
-
Construction
Korea’s Samsung C&T to build modular homes in Saudi Arabia
Samsung C&T Corp., the construction and trading arm of South Korea’s top conglomerate Samsung Group, is set to build modular homes in Saud...
Jan 25, 2023 (Gmt+09:00)
-
Shareholder activism
K-pop label SM taps activist investor as board member
K-pop behemoth SM Entertainment Co. said on Jan. 20 it has decided to tap Lee Chang-hwan, the CEO of local activist fund Align Partners Capital Mana...
Jan 20, 2023 (Gmt+09:00)
-
ECM/DCM
Kakao Pay and Hanwha Aerospace likely to be added to MSCI Korea Index
South Korea's Kakao Pay Corp. and Hanwha Aerospace Co. next month are expected to get newly incorporated into the MSCI Korean Index, which measures ...
Jan 20, 2023 (Gmt+09:00)
-
Energy
Doosan Enerbility acquires US design approval for metal nuclear cask
South Korea's energy equipment maker Doosan Enerbility Co. has obtained the green light in participating in the domestic nuclear storage cask market...
Jan 19, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's Sanfilippo treatment eligible for FDA priority review
GC Biopharma Corp. said on Wednesday that its Sanfilippo type A treatment, which is under joint development with Novel Pharma, a bio-venture special...
Jan 18, 2023 (Gmt+09:00)
-
Aerospace & Defense
S.Korean fighter jet KF-21 makes first supersonic flight
The first prototype of the South Korean fighter jet KF-21 Boramae on Tuesday made its first supersonic flight six months since its inaugural trip to...
Jan 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for EMA approval of smaller dose formulation of Yuflyma
Celltrion Inc. announced on Monday it applied to the European Medicines Agency (EMA) for approval of a 20 mg/0.2 mL formulation of Yuflyma, a biosim...
Jan 16, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Biomedics gets approval for Parkinson's disease clinical trials
South Korea's biomedicine firm S.Biomedics said on Friday that it has won approval from the Ministry of Food and Drug Safety for phase 1 and 2a clin...
Jan 13, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N gets approval to sell K-CAB in Singapore
South Korean biohealth company HK inno.N said on Wednesday that it has received an item approval for K-CAB, a new drug for gastroesophageal reflux d...
Jan 12, 2023 (Gmt+09:00)
-
Airlines
Jeju Air ranked first in domestic routes last year
Jeju Air Co. took first place with an 18.2% share of domestic routes in 2022 for the third straight year from 2020.The airline said on Monday that...
Jan 09, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience's shingles vaccine obtains product approval from Malaysia
SK Bioscience Co. said on Monday that its shingles vaccine Sky Zoster has been given approval by Malaysia's National Pharmaceutical Regulatory Age...
Jan 09, 2023 (Gmt+09:00)